Adoram Therapeutics (Pre-Seed)

Funding Details
Awarder
Inbox
Date Award
February 25, 2025
Vertical
Biotechnology
Funding URL
View Funding Page

Company Info
Company Description
Adoram Therapeutics is a company that uses the benefits of allosteric biochemistry to develop novel therapies.
Market
Cancer Immunotherapy and Inflammation
Location
Switzerland

Links
Back to Home Back to Biotechnology Deals View Funding Announcement